Competitive Advantages
- Specific inhibition of Leishmania donovani parasites
- A natural drug candidate
- Does not produce toxic side effects
Summary
Our researchers have identified a novel metabolite derived from an Antarctic marine coral that shows promise as a new treatment option for leishmaniasis infections. Antactic marine invertebrates are being investigated for their natual chemical protective mechanisms used against predators. This natural product chemistry is ideal for new drug development efforts. The identified metabolite has exhibited specific inhibition of Leishmania donovani parasites in laboratory settings.
A Leishmaniasis Infection at the Cellular Level
Desired Partnerships
- License
- Sponsored Research
- Co-Development